Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes: A Narrative Review of Who Needs Fibrosis Staging and When. Journal of Clinical Diabetes and Obesity, [S. l.], v. 3, n. 1, p. 19–24, 2023. DOI: 10.5281/zenodo.22258263. Disponível em: https://pragmajournals.org/index.php/JCDO/article/view/325. Acesso em: 30 oct. 2026.